Cetas Healthcare | Regulatory Support
A global firm specializing in customer insights and strategy for the medical devices industry
Medical Market Research Emerging Markets Business Analytics Desk Research Qualitative Quantitative Competitive Intelligence
page-template-default,page,page-id-16301,ajax_fade,page_not_loaded,,qode-title-hidden,side_area_uncovered_from_content,wpb-js-composer js-comp-ver-4.5.3,vc_responsive

Regulatory Support

The road ahead is not the same.

regulatory_support On May 25th, 2017 a novel Medical Device Regulation (MDR) came into effect for the European Union, triggering a transition period of three years before the current Medical Device Directive (MDD) will be obsoleted by May 24th, 2020 .

Even before this date new revisions of the guidelines for the assessment of a Clinical Investigations (MEDDEV 2.7/2, 2015) and performance of a Clinical Evaluation (MEDDEV 2.7/1_Revision 4, 2016) came into force to ascertain an adequate Validation and Assessment of Regulatory Conformity for Medical Devices in Europe.

Simultaneously also for Medical Device Quality Management Systems (QMS) complying with the ISO 13485 standard the transition period to it’s most recent version (ISO 13485:2016) ends by February 28th, 2019. By then a risk based QMS approach needs to be demonstrated to comply with the new standard and obtain the re-certification under ISO 13485:2016, which is critical to our industry.

We offer advice in assessing how your current Medical Device Portfolio and future product releases will be impacted by these novel rules and standards, how to navigate the transition and how to establish an effective compliance to the latest Quality Standards and Regulatory Requirements for Medical Devices.

Delivered through collaboration between:

delivered collaboration